• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性膜抗原摄取与肿瘤血流之间的潜在协同作用对人类前列腺癌侵袭性的预测

Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.

作者信息

Jochumsen Mads Ryø, Sörensen Jens, Tolbod Lars Poulsen, Pedersen Bodil Ginnerup, Frøkiær Jørgen, Borre Michael, Bouchelouche Kirsten

机构信息

Department of Nuclear Medicine & PET-Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200, Aarhus N, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

EJNMMI Res. 2021 Feb 9;11(1):12. doi: 10.1186/s13550-021-00757-y.

DOI:10.1186/s13550-021-00757-y
PMID:33559792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7873172/
Abstract

BACKGROUND

Both prostate-specific membrane antigen (PSMA) uptake and tumour blood flow (TBF) correlate with International Society of Urological Pathology (ISUP) Grade Group (GG) and hence prostate cancer (PCa) aggressiveness. The aim of the present study was to evaluate the potential synergistic benefit of combining the two physiologic parameters for separating significant PCa from insignificant findings.

METHODS

From previous studies of [Rb]Rb positron emission tomography (PET) TBF in PCa, the 43 patients that underwent clinical [Ga]Ga-PSMA-11 PET were selected for this retrospective study. Tumours were delineated on [Ga]Ga-PSMA-11 PET or magnetic resonance imaging. ISUP GG was recorded from 52 lesions.

RESULTS

[Ga]Ga-PSMA-11 maximum standardized uptake value (SUVmax) and [Rb]Rb SUVmax correlated moderately with ISUP GG (rho = 0.59 and rho = 0.56, both p < 0.001) and with each other (r = 0.65, p < 0.001). A combined model of [Ga]Ga-PSMA-11 and [Rb]Rb SUVmax separated ISUP GG > 2 from ISUP GG 1-2 and benign with an area-under-the-curve of 0.85, 96% sensitivity, 74% specificity, and 95% negative predictive value. The combined model performed significantly better than either tracer alone did (p < 0.001), primarily by reducing false negatives from five or six to one (p ≤ 0.025).

CONCLUSION

PSMA uptake and TBF provide complementary information about tumour aggressiveness. We suggest that a combined analysis of PSMA uptake and TBF could significantly improve the negative predictive value and allow non-invasive separation of significant from insignificant PCa.

摘要

背景

前列腺特异性膜抗原(PSMA)摄取和肿瘤血流(TBF)均与国际泌尿病理学会(ISUP)分级组(GG)相关,因此与前列腺癌(PCa)的侵袭性相关。本研究的目的是评估将这两个生理参数结合起来以区分有意义的PCa与无意义的检查结果的潜在协同效益。

方法

从先前关于PCa中[Rb]Rb正电子发射断层扫描(PET)TBF的研究中,选择43例行临床[Ga]Ga-PSMA-11 PET检查的患者进行这项回顾性研究。在[Ga]Ga-PSMA-11 PET或磁共振成像上勾勒出肿瘤。记录了52个病灶的ISUP GG。

结果

[Ga]Ga-PSMA-11最大标准化摄取值(SUVmax)和[Rb]Rb SUVmax与ISUP GG中度相关(rho = 0.59和rho = 0.56,均p < 0.001),且彼此相关(r = 0.65,p < 0.001)。[Ga]Ga-PSMA-11和[Rb]Rb SUVmax的联合模型将ISUP GG > 2与ISUP GG 1 - 2及良性病变区分开来,曲线下面积为0.85,灵敏度为96%,特异性为74%,阴性预测值为95%。联合模型的表现明显优于单独使用任何一种示踪剂(p < 0.001),主要是通过将假阴性从五六个减少到一个(p ≤ 0.025)。

结论

PSMA摄取和TBF提供了关于肿瘤侵袭性的互补信息。我们建议对PSMA摄取和TBF进行联合分析可显著提高阴性预测值,并允许非侵入性地区分有意义的与无意义的PCa。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/f692c703f1be/13550_2021_757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/470a2206e3aa/13550_2021_757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/011694885c3c/13550_2021_757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/189ce4c3a99f/13550_2021_757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/7ca934f90e86/13550_2021_757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/cb094479c52f/13550_2021_757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/f692c703f1be/13550_2021_757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/470a2206e3aa/13550_2021_757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/011694885c3c/13550_2021_757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/189ce4c3a99f/13550_2021_757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/7ca934f90e86/13550_2021_757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/cb094479c52f/13550_2021_757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a512/7873172/f692c703f1be/13550_2021_757_Fig6_HTML.jpg

相似文献

1
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.前列腺特异性膜抗原摄取与肿瘤血流之间的潜在协同作用对人类前列腺癌侵袭性的预测
EJNMMI Res. 2021 Feb 9;11(1):12. doi: 10.1186/s13550-021-00757-y.
2
Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na/K-ATPase-density.放射性铷-82 PET、磁共振成像和钠钾-ATP 酶密度检测预测人类前列腺癌侵袭性的肿瘤血流:一项研究
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):532-542. doi: 10.1007/s00259-020-04998-2. Epub 2020 Aug 18.
3
Diagnostic accuracy of Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of Ga-PSMA PET to mpMRI.使用全层病理检测前列腺中级前列腺癌时,镓标记前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)和多参数(mp)MRI的诊断准确性:在mpMRI中添加镓标记PSMA PET的影响
BJU Int. 2019 Nov;124 Suppl 1:42-49. doi: 10.1111/bju.14794. Epub 2019 Jul 9.
4
The additional value of Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy.Ga-PSMA PET/CT SUVmax 在预测前列腺癌活检中 ISUP GG≥2 和 ISUP GG≥3 中的附加价值。
Prostate. 2024 Aug;84(11):1025-1032. doi: 10.1002/pros.24716. Epub 2024 May 5.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Diagnostic value of integrated F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer.集成F-PSMA-1007 PET/MRI与双参数MRI在检测前列腺癌方面的诊断价值比较
Prostate Int. 2022 Jun;10(2):108-116. doi: 10.1016/j.prnil.2022.03.003. Epub 2022 Mar 28.
7
Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer.镓-PSMA PET/CT 用于高危前列腺癌的原发淋巴结和远处转移 NM 分期。
J Nucl Med. 2021 Feb;62(2):214-220. doi: 10.2967/jnumed.120.245605. Epub 2020 May 22.
8
SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.SUVmax/ADC比值作为未经活检的原发性前列腺癌诊断的分子影像生物标志物
Indian J Nucl Med. 2021 Oct-Dec;36(4):377-384. doi: 10.4103/ijnm.ijnm_62_21. Epub 2021 Dec 15.
9
Combined Utility of Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与多参数磁共振成像联合预测前列腺穿刺活检病理。
Eur Urol Oncol. 2022 Jun;5(3):314-320. doi: 10.1016/j.euo.2021.02.006. Epub 2021 Mar 23.
10
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.

引用本文的文献

1
Influence of fasting prior to F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake.F-rhPSMA-7.3(氟托泊司他F-18)PET/CT检查前禁食对生物分布和肿瘤摄取的影响。
EJNMMI Res. 2024 Nov 12;14(1):104. doi: 10.1186/s13550-024-01165-8.
2
Whole-body parametric mapping of tumour perfusion in metastatic prostate cancer using long axial field-of-view [O]HO PET.使用长轴向视野[O]HO PET 对转移性前列腺癌进行肿瘤灌注的全身参数成像。
Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4134-4140. doi: 10.1007/s00259-024-06799-3. Epub 2024 Jun 28.
3
Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, Ga-PSMA PET/CT, PSA, and PSA-density comparison study.

本文引用的文献

1
PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?正电子发射断层成像术(PET)肿瘤灌注成像:一种潜在的癌症生物标志物?
Semin Nucl Med. 2020 Nov;50(6):549-561. doi: 10.1053/j.semnuclmed.2020.07.001. Epub 2020 Aug 7.
2
Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na/K-ATPase-density.放射性铷-82 PET、磁共振成像和钠钾-ATP 酶密度检测预测人类前列腺癌侵袭性的肿瘤血流:一项研究
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):532-542. doi: 10.1007/s00259-020-04998-2. Epub 2020 Aug 18.
3
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence.
前列腺癌患者的格里森评分可以预测吗?一项动态对比增强 MRI、Ga-PSMA PET/CT、PSA 和 PSA 密度比较研究。
Diagn Interv Radiol. 2023 Sep 5;29(5):647-655. doi: 10.4274/dir.2023.232186. Epub 2023 Jul 3.
4
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of Lu-PSMA-617 in prostate cancer patients.利用影像数据评估前列腺癌患者 Lu-PSMA-617 药代动力学变异性的群体药代动力学剂量学模型。
CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1060-1071. doi: 10.1002/psp4.12914. Epub 2023 Feb 9.
5
Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by Ga-PSMA PET/CT.通过镓-PSMA PET/CT检测评估前列腺癌患者生化复发的预测因素
Diagnostics (Basel). 2022 Jan 14;12(1):195. doi: 10.3390/diagnostics12010195.
前列腺特异性膜抗原靶向 PET 成像在前列腺癌复发中的应用。
Curr Opin Urol. 2020 Sep;30(5):635-640. doi: 10.1097/MOU.0000000000000793.
4
The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma.血流代谢比值可能预测局部晚期食管鳞状细胞癌患者的治疗反应和生存情况。
EJNMMI Res. 2020 May 29;10(1):57. doi: 10.1186/s13550-020-00647-9.
5
Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer.镓-PSMA PET/CT 用于高危前列腺癌的原发淋巴结和远处转移 NM 分期。
J Nucl Med. 2021 Feb;62(2):214-220. doi: 10.2967/jnumed.120.245605. Epub 2020 May 22.
6
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT(proPSMA):一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
7
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.影响多参数磁共振成像检测临床显著前列腺癌性能变异性的因素:系统文献回顾。
Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17.
8
Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [C]-Acetate PET/CT.作为前列腺癌侵袭性指标的碳通量:[C]-乙酸 PET/CT。
Int J Med Sci. 2020 Jan 14;17(2):214-223. doi: 10.7150/ijms.39542. eCollection 2020.
9
Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is Ga-PSMA PET/CT guided biopsy the future?镓-PSMA PET/CT在MRI和经会阴前列腺活检后能更好地对局限性前列腺癌进行特征描述:镓-PSMA PET/CT引导下的活检会是未来的发展方向吗?
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1843-1851. doi: 10.1007/s00259-019-04620-0. Epub 2020 Jan 7.
10
Ga-PSMA I&T PET/CT for primary staging of prostate cancer.镓-PSMA I&T PET/CT用于前列腺癌的初始分期
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):168-177. doi: 10.1007/s00259-019-04524-z. Epub 2019 Sep 16.